Comparative effectiveness of three myopia-control spectacle lenses in Chinese children: a real-world retrospective cohort study

The human eye is a living organ that grows and changes, particularly during childhood. In a healthy eye, light focuses precisely on the back surface, allowing for clear vision. However, when the eye grows too long from front to back, light focuses in front of the retina instead, resulting in nearsightedness, or myopia. This elongation is not merely a refractive error; it is a structural change that carries significant risks. As the eye stretches, the delicate tissues inside become thinner and more vulnerable, increasing the likelihood of serious complications later in life, such as retinal detachment or glaucoma. Because this growth happens most rapidly in children, slowing it down has become a critical goal for eye doctors worldwide.

For decades, the standard solution was a simple single-vision lens, which corrects the blurry vision but does nothing to stop the eye from continuing to grow. In recent years, however, optical engineers have developed special spectacle lenses designed to do more than just correct vision. These new lenses incorporate complex patterns that send specific signals to the eye, essentially telling it to pause its growth. Three distinct designs have emerged as the leading contenders in this field. One uses a central clear zone surrounded by a ring of tiny segments to create a specific type of blur. Another relies on a series of concentric rings of tiny lenslets to generate a three-dimensional volume of defocus. The newest approach uses microscopic elements to slightly reduce the contrast of the image on the retina, a mechanism that differs fundamentally from the other two. While each design has been tested individually against standard glasses, doctors and families have lacked a clear, direct comparison of how these three specific technologies perform against one another in the messy reality of daily life.

A team of researchers at the Suzhou Eye Hospital in China set out to fill this gap by looking at the records of hundreds of children who had already been treated with these lenses. They conducted a retrospective study, meaning they gathered data from past patient visits rather than assigning treatments in a controlled experiment. The study included 682 children between the ages of six and sixteen who wore either standard single-vision glasses or one of the three specialized myopia-control lenses. The researchers focused on two main measurements: how much the eye grew longer over the course of a year, and how much the prescription changed. By carefully adjusting for factors like the child's age, gender, and how nearsighted they were at the start, the team could isolate the true effect of the lenses themselves.

The results painted a clear picture of effectiveness. All three specialized lens designs proved superior to standard single-vision glasses in slowing down the lengthening of the eye. Children wearing the standard glasses saw their eyes grow longer by an average of 0.275 millimeters over the year. In contrast, those wearing the lens with the ring of segments saw an average growth of 0.191 millimeters, and those with the concentric ring lenslets saw 0.180 millimeters. The most dramatic difference came from the newest technology, the contrast-reducing lens. Children wearing this design experienced an average eye growth of only 0.092 millimeters. This represented a reduction in growth of roughly two-thirds compared to the standard glasses, a statistically significant advantage that placed this design ahead of the other two specialized options.

When the researchers looked at the change in prescription, the trend held true, though the differences were slightly less pronounced. All three specialized lenses significantly reduced the rate at which the children's nearsightedness worsened compared to the standard glasses. The contrast-reducing lens again showed the strongest performance, followed closely by the other two designs, which performed similarly to each other. The study also examined how many children responded well to the treatment, defined as having very little eye growth or prescription change. The standard glasses resulted in a good response for about 42 percent of the children. The specialized lenses improved these odds significantly, with the contrast-reducing lens achieving a good response in over 70 percent of the wearers, while the other two designs hovered around 56 to 58 percent.

The researchers noted that age played a crucial role in these outcomes. Younger children tended to have faster eye growth and were less likely to achieve a good response, regardless of the lens they wore. This suggests that the window for the most effective intervention is early in childhood. The study also highlighted a limitation in the data: because the follow-up vision tests were often done without fully numbing the eye's focusing muscles, the measurements of prescription change were slightly less precise than the measurements of eye length. Consequently, the researchers placed greater weight on the eye length data, which is an objective physical measurement.

While the findings are compelling, the authors are careful to frame them as real-world observations rather than definitive proof of superiority. The study was not a randomized trial where children were assigned lenses by chance; instead, the lenses were prescribed based on the doctor's judgment and the family's preference. This means that the groups were not perfectly matched at the start, with the children wearing the newest lens being slightly younger and more nearsighted than the others. Despite these children starting with characteristics that usually predict faster eye growth, the newest lens still outperformed the others. This suggests the treatment effect is robust, but the authors acknowledge that unmeasured factors, such as how much time children spent outdoors or how strictly they wore their glasses, could influence the results.

Ultimately, this study provides a valuable snapshot of how these technologies perform outside the controlled environment of a clinical trial. It confirms that all three modern lens designs offer a meaningful benefit over standard glasses for slowing eye growth in Chinese children. Among them, the contrast-reducing lens demonstrated the largest effect and the highest probability of success in this specific group. The researchers conclude that while these real-world results are encouraging, they are not the final word. To truly determine the best optical strategy for every child, future studies will need to be prospective, randomized, and long-term, ensuring that the choice of lens is based on the most rigorous evidence possible.